Japan Biobanking Market Overview

Market Size in 2024: USD 3,803 Million
Market Forecast in 2033: USD 5,611 Million
Market Growth Rate 2025-2033: 4.4%

According to IMARC Group's latest research publication, "Japan Biobanking Market Report by Specimen Type, Biobank Type, Application, End User, and Region 2025-2033," the Japan biobanking market size reached USD 3,803 Million in 2024. IMARC Group expects the market to reach USD 5,611 Million by 2033, exhibiting a growth rate (CAGR) of 4.4% during 2025-2033. The market is driven by the increasing demand for personalized medicine, advancements in genomic research, and rising investments in biobanking infrastructure by public and private sectors.

Download a Free Sample PDF of this report: https://www.imarcgroup.com/japan-biobanking-market/requestsample

Growth Factors in the Japan Biobanking Market

Demand for Personalized Medicine
The growing focus on precision medicine, which tailors treatments to individual genetic profiles, fuels demand for biobanking. In 2024, the Kanto Region saw a 12% increase in biobank-supported research for personalized therapies, particularly for cancer and cardiovascular diseases, supporting a projected CAGR of 4.6%. This is driven by initiatives like the Japan Agency for Medical Research and Development (AMED)’s Genomic Medicine Realization Project.

Advancements in Genomic Research
Technological advancements in genomics, such as next-generation sequencing, enhance the utility of biobanks. In the Kansai Region, genomic research projects utilizing biobank samples grew by 10% in 2024, with institutions like BioBank Japan providing DNA samples from 270,000 patients. This contributes to a CAGR of 4.5% for research-driven biobanking.

Rising Prevalence of Chronic Diseases
The increasing incidence of chronic diseases, such as cancer (1.1 million new cases annually in Japan) and cardiovascular conditions, drives demand for biobanking to support biomarker discovery and therapeutic development. In the Chubu Region, disease-oriented biobanks for cancer research expanded by 15% in 2024, supporting a CAGR of 4.7%.

Government and Private Investments
Significant funding from government bodies and private organizations supports biobanking infrastructure. The National Center Biobank Network (NCBN), coordinating six national centers, received USD 10 million in 2024 for sample storage and data management, particularly in the Kyushu-Okinawa Region. This drives a CAGR of 4.3% for infrastructure development.

Key Trends in the Japan Biobanking Market

Blood Products Lead Specimen Type
Blood products held a 40% market share in 2024 due to their ease of collection and critical role in genetic research and diagnostics. In the Hokkaido Region, blood sample storage for hematological studies increased by 18%, with a projected CAGR of 4.8%. Solid tissue and nucleic acid segments are also growing, driven by regenerative medicine, with CAGRs of 4.2% and 4.5%, respectively.

Disease-Oriented Biobanks Dominate
Disease-oriented biobanks accounted for 60% of the market share in 2024, focusing on specific conditions like cancer and neurological disorders. In the Tohoku Region, biobanks targeting rare diseases grew by 12%, supported by BioBank Japan’s collection of samples from 51 diseases. This segment is projected to grow at a CAGR of 4.9%.

Research Applications Lead
The research segment held a 55% market share in 2024, driven by biobanks providing samples for clinical and genomic studies. In the Chugoku Region, research using biobank samples for biomarker discovery rose by 15%, with a projected CAGR of 4.7%. The therapeutics segment, focusing on drug development, is growing at a CAGR of 4.3%.

Pharma and Biotech Companies as Key End Users
Pharma and biotech companies held a 58% market share in 2024, driven by their need for high-quality samples for drug development and clinical trials. In the Kanto Region, companies like Takeda utilized biobank samples for oncology research, with a 20% increase in demand. This segment is expected to grow at a CAGR of 4.6%, while academic institutions grow at 4.2%.

Japan Biobanking Market Industry Segmentation

The report has segmented the market into the following categories:
The market report offers a comprehensive analysis of the segments, highlighting those with the largest Japan Biobanking Market Share. It includes forecasts for the period 2025-2033 and historical data from 2019-2024 for the following segments.

Specimen Type Insights:

• Blood Products
• Solid Tissue
• Cell Lines
• Nucleic Acid
• Others

Biobank Type Insights:

• Population-based Biobanks
• Disease-oriented Biobanks

Application Insights:

• Therapeutics
• Research

End User Insights:

• Academic Institutions
• Pharma and Biotech Companies

Regional Insights

• Kanto Region
• Kansai/Kinki Region
• Central/Chubu Region
• Kyushu-Okinawa Region
• Tohoku Region
• Chugoku Region
• Hokkaido Region
• Shikoku Region

Ask Analyst for Sample Report: https://www.imarcgroup.com/request?type=report&id=18685&flag=C

Competitive Landscape

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Future Outlook

The Japan biobanking market is poised for steady growth through 2033, driven by the increasing adoption of precision medicine, advancements in genomic research, and government-backed initiatives like AMED’s Genomic Medicine Realization Project. Urban regions like Kanto and Kansai will lead due to high research activity and infrastructure investments. Challenges include ethical and legal concerns, with APPI compliance increasing operational costs by 10–15%, and limited public awareness, particularly in rural areas like Shikoku. However, advancements in AI-driven data analytics and cryogenic storage will support market expansion.

Research Methodology

The report employs a comprehensive research methodology, combining primary and secondary data sources to validate findings. It includes market assessments, surveys, expert opinions, and data triangulation techniques to ensure accuracy and reliability.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact:
Street: 563-13 Kamien
Area: Iwata
Country: Tokyo, Japan
Postal Code: 4380111
Email: sales@imarcgroup.com